This landmark deal puts CBD in drug stores across the country.

The breakthrough I’ve been predicting since December has finally come!

It was in December that I proclaimed the Farm Bill would be bigger than anyone was expecting and that it would usher in the Year of CBD in 2019. There has been a lot happening in CBD since then, including an 83% appreciation on one of the CBD stocks in our exclusive Cannabis Investor’s Report portfolio and a 50% return on the second pick.

But last week CVS laid to rest any doubt about my prediction – 2019 is the year of CBD.

The largest pharmacy chain in the U.S. started carrying CBD lotions and pain patches in 800 of its stores across eight states. This is the first large chain drugstore to carry CBD products.

And it’s difficult to overstate just how important this announcement is.

CVS is such a conservative store that it discontinued selling cigarettes a few years ago because it is positioning itself as a health brand.

Its parent company has purchased a pharmacy benefit manager, and it is establishing nursing stations in its stores.

It even bought Aetna.

CVS intends to be a big name in health care. So their endorsement of CBD as a general health product is about as big as you can get.

Here’s why…

The First of Many

Previously we saw Green Growth Brands (CSE: GGB, OTC: GGBXF) announce its intention to sell CBD products in DSW shoe stores. That is also an important announcement but its significance pales in comparison to the CVS deal for two reasons.

First, there are only 500 DSW stores in the country. Compare that to the 800 stores for CVS’s initial rollout and the 9,300 total CVS stores in the country. It’s clear that the CVS deal is much larger.

The second reason is that DSW is controlled by the same family that controls Green Growth Brands. Green Growth Brands convincing DSW to sell CBD was doubtless a little easier than convincing CVS to take the leap.

CVS will benefit from their deal, of course, when they sell a lot of CBD products. But another company will benefit even more.

A Big Win for this Cannabis Leader

Curaleaf Holdings Inc. (CSE: CURA, OTC: CURLF) is the company which got the historic first contract.

Curaleaf is mostly known as a cannabis company, but just about every cannabis company is getting into CBD products. They see that CBD will grow even more quickly than THC-containing cannabis and there is a similar expertise in extracting CBD in THC from cannabis plants.

Curaleaf is one of the stocks in our exclusive Cannabis IPO Insider portfolio, so those subscribers are yet another beneficiary of this big CVS deal. The stock appreciated by 50% in just two days, and The Cannabis IPO Insider members who purchased the stock when I first recommended it are sitting on a gain of nearly 70% in less than 4 months.

For smart investors who target cannabis stocks on IPO day, the gains can be incredible. We’re talking about the potential for each of these stocks to soar 200%, 500%, 1,000%, or more, practically overnight. And today, we’ve uncovered the next high-flying companies set to go public that you can’t afford to miss out on. Just click here to find out more.

This is not the last big deal you’ll read about involving CBD and national chains – not by a long shot. CVS will expand this program and probably sign up other vendors.

Walgreens and Rite Aid won’t be far behind, and it’s only a matter of time before CBD products are available at grocery stores and even big-box retailers. And that means that there are more gains ahead for the companies which sign these big companies up as customers.

Thanks for being an important part of the National Institute for Cannabis Investors,

Greg Miller

Executive Director, National Institute for Cannabis Investors

P.S. I want to take your investing to the next level…I’d like to give you FULL ACCESS to the enormous wealth potential hidden inside “The Marijuana Millionaire’s Vault.” It contains everything you would ever want to know about EVERY publicly traded cannabis company. The Vault also contains the most promising new startups… companies our research suggests could become the next breakout company of the cannabis industry. Plus, you’ll also be kept in the loop on cannabis IPOs that have the potential to give you the biggest paydays you’ll ever see in your life. In short, It’s the most comprehensive database of cannabis stocks in existence, bar none. It holds everything you need to help you get the jump on other investors… and potentially make an absolute fortune. And all you have to do is click here to get this valuable tool at your fingertips.


7 responses to “CBD at CVS Is a Big Win for This Cannabis Stock”

  1. Great inspiring article, I’m not an IPO insider but I chose this company along with some other MSO’s that have done just as well. Harvest Health and Recreation will be the next of the big MSO’s to land a big deal with a drug store chain. Curaleaf expanding into California and Nevada is also just as big for its shareholders as we are expanding out footprint into the largest markets in the country.

  2. I as well am not an IPO insider, but I do own some CVS stock. I think your advice is good and sound. If I lose out by not being an insider. That’s on me, no one else.

Leave a Reply

Your email address will not be published. Required fields are marked *